These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9726452)

  • 1. PET and recurrent squamous cell carcinoma of the head and neck: a surgeon's view.
    Goodwin WJ
    AJNR Am J Neuroradiol; 1998 Aug; 19(7):1197. PubMed ID: 9726452
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck.
    Fischbein NJ; AAssar OS; Caputo GR; Kaplan MJ; Singer MI; Price DC; Dillon WP; Hawkins RA
    AJNR Am J Neuroradiol; 1998 Aug; 19(7):1189-96. PubMed ID: 9726451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron-emission tomography for surveillance of head and neck cancer.
    Ryan WR; Fee WE; Le QT; Pinto HA
    Laryngoscope; 2005 Apr; 115(4):645-50. PubMed ID: 15805874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography.
    Farber LA; Benard F; Machtay M; Smith RJ; Weber RS; Weinstein GS; Chalian AA; Alavi A; Rosenthal DI
    Laryngoscope; 1999 Jun; 109(6):970-5. PubMed ID: 10369292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct comparison of F-18-FDG PET and ultrasound in the follow-up of patients with squamous cell cancer of the head and neck.
    Goerres GW; Haenggeli CA; Allaoua M; Albrecht SR; Dulguerov P; Becker M; Allal AS; Lehmann W; Slosman DO
    Nuklearmedizin; 2000 Dec; 39(8):246-50. PubMed ID: 11189902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uses and limitations of FDG positron emission tomography in patients with head and neck cancer.
    Hanasono MM; Kunda LD; Segall GM; Ku GH; Terris DJ
    Laryngoscope; 1999 Jun; 109(6):880-5. PubMed ID: 10369275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma.
    Wong WL; Chevretton EB; McGurk M; Hussain K; Davis J; Beaney R; Baddeley H; Tierney P; Maisey M
    Clin Otolaryngol Allied Sci; 1997 Jun; 22(3):209-14. PubMed ID: 9222623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of (18) FDG PET-CT for treatment evaluation 3 months after completion of chemoradiotherapy for head and neck squamous cell carcinoma: 2-year minimum follow-up.
    Sagardoy T; Fernandez P; Ghafouri A; Digue L; Haaser T; de Clermont-Galleran H; Castetbon V; de Monès E
    Head Neck; 2016 Apr; 38 Suppl 1():E1271-6. PubMed ID: 26315809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting Residual/Recurrent Head Neck Squamous Cell Carcinomas Using PET or PET/CT: Systematic Review and Meta-analysis.
    Cheung PK; Chin RY; Eslick GD
    Otolaryngol Head Neck Surg; 2016 Mar; 154(3):421-32. PubMed ID: 26715675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of PET FDG in the management of head and neck squamous cell cancer.
    Wong WL; Saunders M
    Clin Oncol (R Coll Radiol); 1998; 10(6):361-6. PubMed ID: 9890536
    [No Abstract]   [Full Text] [Related]  

  • 11. Does 18fluoro-fluorodeoxyglucose positron emission tomography improve recurrence detection in patients treated for head and neck squamous cell carcinoma with negative clinical follow-up?
    Salaun PY; Abgral R; Querellou S; Couturier O; Valette G; Bizais Y; Kraeber-Bodéré F
    Head Neck; 2007 Dec; 29(12):1115-20. PubMed ID: 17636537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thallium-201 single-photon emission CT in recurrent squamous cell carcinoma of the head and neck.
    O'Tuama LA; Poussaint TY
    AJNR Am J Neuroradiol; 2002 Jan; 23(1):174-5. PubMed ID: 11827893
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
    Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
    Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of positron emission tomography for early detection of recurrent head and neck squamous cell carcinoma in postradiotherapy patients.
    Bailet JW; Sercarz JA; Abemayor E; Anzai Y; Lufkin RB; Hoh CK
    Laryngoscope; 1995 Feb; 105(2):135-9. PubMed ID: 8544591
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Kim SA; Roh JL; Kim JS; Lee JH; Lee SH; Choi SH; Nam SY; Kim SY
    Eur J Cancer; 2017 Feb; 72():62-70. PubMed ID: 28027517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of PET/CT in maxillo-facial surgery.
    Wong WL; Batty V
    Br J Oral Maxillofac Surg; 2009 Jun; 47(4):259-67. PubMed ID: 19200626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma.
    Wong RJ; Lin DT; Schöder H; Patel SG; Gonen M; Wolden S; Pfister DG; Shah JP; Larson SM; Kraus DH
    J Clin Oncol; 2002 Oct; 20(20):4199-208. PubMed ID: 12377963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of
    Ha SC; Roh JL; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY
    Acta Otolaryngol; 2019 Sep; 139(9):810-815. PubMed ID: 31274365
    [No Abstract]   [Full Text] [Related]  

  • 19. Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma.
    Lee JR; Choi YJ; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1020-7. PubMed ID: 26122372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neck dissection can be avoided after sequential chemoradiotherapy and negative post-treatment positron emission tomography-computed tomography in N2 head and neck squamous cell carcinoma.
    Loo SW; Geropantas K; Beadsmoore C; Montgomery PQ; Martin WM; Roques TW
    Clin Oncol (R Coll Radiol); 2011 Oct; 23(8):512-7. PubMed ID: 21501953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.